Germine monoacetate and 3-chloro-2,5,6,-trimethyl-benzoic acid; therapeutic possiblities against inhibition of neuromuscular transmission by organophosphorus anticholinesterase compounds.
D000470:Alkaloids / Q000627:therapeutic use*; D000818:Animals; D001565:Benzoates / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000037:antagonists & inhibitors*; D007531:Isoflurophate / Q000037:antagonists & inhibitors; D008297:Male; D009467:Neuromuscular Depolarizing Agents / Q000037:antagonists & inhibitors*; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology*; D009596:Nitrophenols / Q000037:antagonists & inhibitors; D010756:Phosphoric Acids / Q000037:antagonists & inhibitors; D051381:Rats
D000470:Alkaloids; D001565:Benzoates; D002800:Cholinesterase Inhibitors; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D009596:Nitrophenols; D010756:Phosphoric Acids; D007531:Isoflurophate